Latest News

Press Release
Sweet Ventures invests in BOYDSense to bring non-invasive glucose monitoring using breath analysis to people with diabetes
Press Release
BOYDSense diabetes device places among top innovations at 2019 RESI Innovation Challenge
San Bruno, Calif. – October 29, 2019 – Medical technology company BOYDSense, Inc. has returned from the RESI (Redefining Early Stage Investments) conference in Boston with a second-place finish in the RESI Innovation Challenge and myriad accolades […]
From 38 Finalists. RESI Boston’s Audience Selects Innovation Challenge Champions
Boston, Mass. - September 12, 2019 - The RESI Innovation Challenge showcased 38 emerging startups in the biotech, medtech, diagnostics and digital health fields. All the competitors brought novel, exciting discoveries to the technology showcase […]

Ambrosia Investments and Jolt Capital are majority shareholders in BOYDSense’s parent company Alpha-MOS.


Here are a few of the honors we’ve received


For all media inquiries please email us at: